A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.

The maker of a new anti-clotting medication may have withheld important safety information from regulators, according to several new reports.

One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.

Pulmonary embolism is a condition that can strike suddenly, sometimes with deadly consequences. New research on treatments for the condition could lead to better outcomes and understanding of risk factors.

It is normal for new mothers to be at risk for a blood clot for six weeks after giving birth. However, a new study suggests that women may still be at risk after those first six weeks.

Diverticulosis — the presence of small pockets in the walls of the colon — is a very common digestive condition among older people. Researchers recently explored if diverticular diseases raised risks for cardiovascular disease.

Venous thromboembolism (VTE) is rare in children, which often causes it to be overlooked, leading to delays in treatment that can sometimes be deadly.

The more that has been learned about the first few days of a baby's life, the more doctors understand about how to keep newborns healthy. But parents are partners in treatment too.

When a woman is pregnant, the hormones her body makes can increase her risk of experiencing a blood clot. Other factors might increase this risk further.

Mesh tubes called stents can help keep blood vessels open in people with blocked arteries. To prevent blood clots from forming in stents, patients take anti-clotting agents, but it has not been clear how long this therapy should last.